Concentrix (CNXC) Q3 2026 earnings review
Concentrix expands margins, but shrinking revenue forces another massive write-down
Concentrix expanded its profit margins and hit a milestone in its artificial intelligence transition, but its top line went backward. Total revenue shrank 1% and missed the company's own target, dragged down by drops in its technology and healthcare segments. Despite the revenue miss, lower costs pushed adjusted profit per share up 5%.
| Revenue excluding currency impacts | -0.5% from a year ago |
|---|---|
| Profit per share, excluding one-offs | $2.92 +5% from a year ago |
| Adjusted free cash flow | $218 million +22% from a year ago |
| Full-year revenue outlook | Cut $123M middle of the range: flat for the year |
⚖️ Verdict: 🔴 Bearish
The standing case got worse because the legacy business is eroding faster than the new platform can replace it. The bad news: management cut the full-year revenue outlook again, and the low stock price forced a second significant write-down on the balance sheet.
The question now is whether the new contracts can grow fast enough to catch up with the runoff in the traditional call-center work. Next quarter's constant-currency revenue growth will show if the bleeding has stopped.
🐂 Bull Case
New Tech Wins Now Drive Half of Revenue
Concentrix reached a turning point in its transition from legacy call centers to technology services. Business won in the last three years since introducing its artificial intelligence platform now accounts for half of total revenue.
Management previously noted that this newer work carries better margins once deployed. The milestone shows the company is successfully selling complex software setups to its clients, rather than just leasing them offshore labor.
What to watch: whether total revenue returns to growth as this cohort overtakes the declining legacy contracts.
Lower Costs Expanded the Profit Margin
The company's recent restructuring program is offsetting the top-line drop. Profit excluding one-offs rose to 12.6% of revenue, up from 12.3% a year ago and beating management's own target.
The company achieved the expansion by holding its selling, general and administrative expenses flat from a year ago while shifting more of its remaining workforce to offshore centers. The tight cost controls allowed profit per share to climb 5% even as revenue shrank.
What to watch: whether the margin holds steady next quarter despite a weaker top-line outlook.
🐻 Bear Case
The Market Valuation Forced Another Write-Down
Management insists the underlying business is getting healthier, but the balance sheet tells a different story. Concentrix took a $1.05 billion non-cash impairment charge against its goodwill this quarter.
The company blamed the write-down squarely on its low stock price and market value. It is the second billion-dollar impairment the company has swallowed in the last year, wiping out its reported profit and underscoring the deep gap between how management and the market view the firm's assets.
What to watch: the gap between adjusted and reported earnings over the next year.
Tech and Healthcare Dragged the Core Down
The company's two weakest segments are eroding faster than the rest of the business can grow. Revenue from technology clients fell 10% from a year ago. Healthcare revenue dropped 17%.
These steep declines overwhelmed 12% growth in the banking sector, pushing total revenue negative for the quarter and causing a miss against the company's own plan.
What to watch: the technology segment next quarter; management previously expected it to remain volatile.
👓 Other Themes
Dividend Returns Replaced Buybacks
The company paused its share repurchases this quarter after buying back stock in the first half of the year. Instead, Concentrix increased its quarterly dividend slightly to 37 cents per share. Management still has about $397 million authorized for future buybacks.
💲 Other KPIs
Up 22% from $179 million a year ago. The company excludes the timing effects of its accounts receivable factoring program from this figure. The strong cash generation covers the dividend and allows for future debt reduction.
Down 2.8% from a year ago. The company paused buybacks this quarter, so the share count reduction comes entirely from stock retired in previous periods.
🔮 Guidance
Cut. The company lowered the middle of its full-year range by about $123 million, pointing to roughly flat revenue for the year. By our math, that leaves fourth-quarter revenue down about 4.6% from a year ago. Management blamed the softer outlook on the transition away from lower-value contracts.
Unchanged. Management narrowed the range around a nearly identical midpoint, proving its confidence in the recent cost cuts. The plan still calls for profit margins to expand in the fourth quarter despite the lower revenue base.
Unchanged. The company kept its full-year cash generation target exactly where it was.
❓ Key Questions
Why did technology and healthcare client volumes drop so sharply?
The two segments fell 10% and 17% from a year ago. Investors need to know if clients are moving work to competitors or abandoning the services entirely.
When will the legacy runoff stop masking the AI growth?
The new platform accounts for half of revenue and carries better margins, but total revenue keeps shrinking. The market needs a timeline for when the total business starts growing again.